Valence Isomerization of Bi-2H-azirin-2-yls to Diazabenzenes
FULL PAPER
Photochemical syntheses of tetraalkylbi-2H-azirin-2-yls 9g, 9j, and 9j’ as
well as 9k, 9k’, and 9k’’: The photochemical transformations of buta-
dienes (E,E)-8g, (E,E)-8j, and (E,E)-8j’ as well as (E,E)-8k, (E,E)-8k’,
and (E,E)-8k’’ were carried out in solution (CDCl3) at temperatures be-
tween ꢀ50 and ꢀ608C. The yields were quantitative. The ratios of 9j:9j’
obtained after photolysis were in accordance with the ratios of the start-
Thermal reactions of tetraalkylbi-2H-azirin-2-yls 9g, 9j, and 9j’ as well
as 9k, 9k’, and 9k’’: After photolyses of the corresponding diazides
(E,E)-8 at ꢀ50 to ꢀ608C, the resulting solutions of 9g, 9j, and 9j’ as well
as 9k, 9k’, and 9k’’ were warmed to temperatures in the range of ꢀ25 to
208C to yield the pyridazines 18 quantitatively. The ratio of the starting
materials 9j and 9j’ were in accordance with the ratio of the thermal
products 18j and 18j’. The same held true for the ratios 9k:9k’:9k’’ and
18k:18k’:18k’’. The heterocyclic aromatic products were isolated by re-
moving the solvent in vacuo. However, if AgBF4 is present, the reaction
mixture must first be washed with aqueous NaBr. Products 18g and 10g
resulting from thermal, silver-ion-induced, or photochemical reactions
were identified by comparing their 1H NMR and 13C NMR data to those
of independently prepared[26,29] samples. These sets of data can be un-
equivocally distinguished from each other and from those of 11g, which
was also synthesized[45] for control experiments including photostability.
ing material (E,E)-8j:
ACHTREUNG
9k:9k’:9k’’ and (E,E)-8k:
A
ACHTREUNG
2,2’,3,3’-Tetramethylbi-2H-azirin-2-yl (9g) (more stable isomer, most
probably meso compound): IR (CDCl3): n˜ =1753 cmꢀ1 (C=N); 1H NMR
(CDCl3, ꢀ508C): d=0.93 (s, 6H; 2-Me/2’-Me), 2.47 ppm (s, 6H; 3-Me/3’-
Me); 13C NMR (CDCl3, ꢀ508C): d=14.53 (q, Me-3/Me-3’), 19.78 (q, Me-
2/Me-2’), 38.95 (s, C-2/C-2’), 176.25 ppm (s, C-3/C-3’).
2,2’,3,3’-Tetramethylbi-2H-azirin-2-yl (9g) (less stable isomer, most prob-
ably rac compound): 1H NMR (CDCl3, ꢀ508C): d=1.16 (s, 6H; 2-Me/2’-
Me), 2.38 ppm (s, 6H; 3-Me/3’-Me); 13C NMR (CDCl3, ꢀ508C): d=14.71
(q, Me-3/Me-3’), 20.25 (q, Me-2/Me-2’), 38.93 (s, C-2/C-2’), 173.75 ppm (s,
C-3/C-3’).
1:2 Mixture of 4-ethyl-3,5,6-trimethylpyridazine (18j) and 3-ethyl-4,5,6-
trimethylpyridazine (18j’): Colorless liquid; MS (ESI): m/z (%): 151.1229
(100) [M+H+; calcd 151.1230], 323.2129 (17) [2M+Na+; calcd 323.2206];
elemental analysis calcd (%) for C9H14N2: C 71.96, H 9.39, N 18.65;
found: C 71.48, H 9.07, N 18.87.
18j: 1H NMR (CDCl3): d=1.11 (t, 3J=7.6 Hz, 3H; 2’-H), 2.21 (s, 3H;
Me-5), 2.57 (s, 3H), 2.61 (s, 3H), 2.63 ppm (q, 3J=7.6 Hz, 2H; 1’-H);
13C NMR (CDCl3): d=12.43 (q), 13.69 (q), 20.01 (q), 20.77 (q), 21.52 (t,
C-1’), 133.56 (s, C-5), 139.37 (s, C-4), 156.85 (s), 157.88 ppm (s).
18j’: 1H NMR (CDCl3): d=1.28 (t, 3J=7.5 Hz, 3H; 2’-H), 2.19 (s, 3H),
2.22 (s, 3H), 2.58 (s, 3H; 6-Me), 2.93 ppm (q, 3J=7.5 Hz, 2H; 1’-H);
13C NMR (CDCl3): d=12.93 (q), 13.78 (q), 14.39 (q), 20.79 (q, Me-6),
27.31 (t, C-1’), 133.55 (s), 134.52 (s), 157.16 (s, C-6), 161.40 ppm (s, C-3).
2-Ethyl-2’,3,3’-trimethylbi-2H-azirin-2-yl (9j) (more stable isomer, most
probably unlike compound): 1H NMR (CDCl3, ꢀ508C): d=0.49 (t, 3J=
7.6 Hz, 3H; CH3CH2), 0.97 (s, 3H; 2’-Me), 1.48–1.60 (m, 2H; CH2), 2.44
(s, 3H), 2.45 ppm (s, 3H); 13C NMR (CDCl3, ꢀ508C): d=10.30 (q,
CH3CH2), 14.32 (q), 15.13 (q), 19.80 (q, Me-2’), 24.00 (t, CH2), 38.54 (s,
C-2’), 43.81 (s, C-2), 174.93 (s), 175.66 ppm (s).
2-Ethyl-2’,3,3’-trimethylbi-2H-azirin-2-yl (9j) (less stable isomer, most
probably like compound): 1H NMR (CDCl3, ꢀ508C): d=0.61 (t, 3J=
7.5 Hz, 3H; CH3CH2), 1.18 (s, 3H; 2’-Me), 1.70–1.84 (m, 2H; CH2), 2.37
(s, 3H), 2.40 ppm (s, 3H); 13C NMR (CDCl3, ꢀ508C): d=10.20 (q,
CH3CH2), 14.60 (q), 15.38 (q), 20.49 (q, Me-2’), 24.77 (t, CH2), 38.01 (s,
C-2’), 43.45 (s, C-2), 172.03 (s), 172.80 ppm (s).
1:2:1 Mixture of 4,5-diethyl-3,6-dimethylpyridazine (18k), 3,4-diethyl-5,6-
dimethylpyridazine (18k’), and 3,6-diethyl-4,5-dimethylpyridazine (18k’’):
Colorless liquid; MS (ESI): m/z (%): 165.1377 (100) [M+H+; calcd
165.1386]; elemental analysis calcd (%) for c10H16N2: C 73.13, H 9.82, N
17.06; found: C 72.75, H 9.79, N 17.24.
3-Ethyl-2,2’,3’-trimethylbi-2H-azirin-2-yl (9j’) (more stable isomer, most
probably unlike compound): 1H NMR (CDCl3, ꢀ508C): d=0.93 (s, 3H),
0.94 (s, 3H), 1.26 (t, 3J=7.4 Hz, 3H; CH3CH2), 2.46 (s, 3H; Me-3’), 2.76
(q, 3J=7.4 Hz, 1H; CH2), 2.78 ppm (q, 3J=7.4 Hz, 1H; CH2); 13C NMR
(CDCl3, ꢀ508C): d=8.59 (q, CH3CH2), 14.53 (q, Me-3’), 19.79 (q), 20.04
(q), 21.96 (t, CH2), 39.01 (s), 39.84 (s), 176.29 (s, C-3’), 179.83 ppm (s, C-
3).
1
3
18k: H NMR (CDCl3): d=1.17 (t, J=7.7 Hz, 6H; 2’-H), 2.65 (s, 6H; 3-
Me/6-Me), 2.65 ppm (q, 3J=7.7 Hz, 4H; 1’-H); 13C NMR (CDCl3): d=
13.50 (q, C-2’), 20.07 (q, Me-3/Me-6), 21.11 (t, C-1’), 138.82 (s, C-4/C-5),
157.44 ppm (s, C-3/C-6).
18k’: 1H NMR (CDCl3): d=1.14 (t, 3J=7.6 Hz, 3H; CH3CH2 at C-4),
3-Ethyl-2,2’,3’-trimethylbi-2H-azirin-2-yl (9j’) (less stable isomer, most
probably like compound): 1H NMR (CDCl3, ꢀ508C): d=1.16 (s, 3H),
1.17 (s, 3H), 1.22 (t, 3J=7.4 Hz, 3H; CH3CH2), 2.34 (s, 3H; Me-3’),
2.66 ppm (q, 3J=7.4 Hz, 2H; CH2); 13C NMR (CDCl3, ꢀ508C): d=8.33
(q, CH3CH2), 14.69 (q, Me-3’), 20.31 (q), 20.57 (q), 22.08 (t, CH2), 38.86
(s), 39.78 (s), 173.53 (s, C-3’), 177.16 ppm (s, C-3).
3
1.34 (t, J=7.5 Hz, 3H; CH3CH2 at C-3), 2.23 (s, 3H; Me-5), 2.60 (s, 3H;
Me-6), 2.67 (q, 3J=7.6 Hz, 2H; CH2 at C-4), 2.94 ppm (q, 3J=7.5 Hz,
2H; CH2 at C-3); 13C NMR (CDCl3): d=13.31 (q), 13.80 (q), 13.85 (q),
20.87 (q, Me-6), 20.94 (t, CH2 at C-4), 26.46 (t, CH2 at C-3), 133.78 (s, C-
5), 138.78 (s, C-4), 157.64 (s, C-6), 161.08 ppm (s, C-3).
1
3
18k’’: H NMR (CDCl3): d=1.34 (t, J=7.5 Hz, 6H; 2’-H), 2.25 (s, 6H; 4-
Me/5-Me), 2.96 ppm (q, 3J=7.5 Hz, 4H; 1’-H); 13C NMR (CDCl3): d=
12.84 (q), 13.91 (q), 27.29 (t, C-1’), 133.86 (s, C-4/C-5), 161.14 ppm (s, C-
3/C-6).
2,2’-Diethyl-3,3’-dimethylbi-2H-azirin-2-yl (9k), 2,3-diethyl-2’,3’-dimethyl-
bi-2H-azirin-2-yl (9k’), 3,3’-diethyl-2,2’-dimethylbi-2H-azirin-2-yl (9k’’)
(more stable isomers, most probably meso or unlike compounds):
1H NMR (CDCl3, ꢀ508C): d=0.52 (t, 3J=7.3 Hz, CH3CH2, 9k), 0.54 (t,
3J=7.4 Hz, CH3CH2 at C-2, 9k’), 0.94 (s, 2-Me/2’-Me, 9k’’), 1.01 (s, 2’-Me,
9k’), 1.29 [t, 3J=7.5 Hz, CH3CH2 at C-3 (9k’)+CH3CH2 (9k’’)], 1.4–1.9
(m, CH2 (9k)+CH2 at C-2 (9k’)), 2.46 (s, 3’-Me, 9k’), 2.47 (s, 3-Me/3’-
Me, 9k), 2.7–2.9 ppm [m, CH2 at C-3 (9k’)+CH2 (9k’’)]; 13C NMR
(CDCl3, ꢀ508C): d=8.56 (q), 8.72 (q), 10.23 (q), 10.32 (q), 14.22 (q),
14.89 (q), 19.71 (q), 19.99 (q), 21.86 (t), 22.25 (t), 24.00 (t), 24.29 (t),
38.47 (s), 39.88 (s), 43.37 (s), 44.85 (s), 174.31 (s), 175.43 (s), 178.50 (s),
179.69 ppm (s).
Reaction of trans-3,4-dibromo-1,2,3,4-tetraphenylcyclobutene [15c (X=
Br)] with QN3: In
a
typical experiment, 15c (X=Br)[12] (21.5 mg,
43.3 mmol) and dioxane (2 mL as standard) were dissolved in CDCl3
(0.7 mL). To this mixture, a solution of QN3 (50.0 mg, 0.106 mmol) in
CDCl3 (0.3 mL) was added at ꢀ508C. The reaction was monitored by
NMR spectroscopy while increasing the temperature stepwise from
ꢀ508C to 608C. Tetraphenylpyridazine 18c (87%) was obtained as the
stable final product and identified by comparing its 1H NMR and
13C NMR data to those of an independently prepared[31] sample. These
data can be unequivocally distinguished from those of 10c[32] and 11c,[33]
which were also synthesized for control experiments including photosta-
bility. The azirine 17c as well as bi-2H-azirin-2-yls meso- and rac-9c
could be observed as intermediates by NMR spectroscopy. The maximum
amount of 17c was 87%.
2,2’-Diethyl-3,3’-dimethylbi-2H-azirin-2-yl (9k), 2,3-diethyl-2’,3’-dimethyl-
bi-2H-azirin-2-yl (9k’), 3,3’-diethyl-2,2’-dimethylbi-2H-azirin-2-yl (9k’’)
(less stable isomers, most probably rac or like compounds): 1H NMR
(CDCl3, ꢀ508C): d=0.677 (t, 3J=7.8 Hz, CH3CH2 at C-2, 9k’), 0.683 (t,
3J=7.5 Hz, CH3CH2, 9k), 1.21 (s, 2-Me/2’-Me, 9k’’), 1.23 (s, 2’-Me, 9k’),
1.24 (t, 3J=7.3 Hz, CH3CH2, 9k’’), 1.27 (t, 3J=7.5 Hz, CH3CH2 at C-3,
9k’), 1.4–1.9 (m, CH2 (9k)+CH2 at C-2 (9k’)), 2.39 (s, 3’-Me, 9k’), 2.42
(s, 3-Me/3’-Me, 9k), 2.7–2.9 ppm (m, CH2 at C-3 (9k’)+CH2 (9k’’));
13C NMR (CDCl3, ꢀ508C): d=8.33 (q), 8.35 (q), 10.09 (q), 10.15 (q),
14.50 (q), 15.13 (q), 20.54 (q), 20.59 (q), 21.98 (t), 22.45 (t), 25.04 (t),
25.10 (t), 37.72 (s), 39.64 (s), 42.27 (s), 44.29 (s), 171.17 (s), 172.38 (s),
175.47 (s), 176.85 ppm (s).
2-(2-Azido-1,2-diphenylethenyl)-2,3-diphenyl-2H-azirine
(17c):
IR
(CDCl3): n˜ =2110 cmꢀ1 (N3), 1738 (C=N), 1255 (N3); 1H NMR (CDCl3):
d=6.88–7.63 ppm (m); 13C NMR (CDCl3): d=44.78 (s, C-2), 123.50 (s),
126.11 (d), 126.37 (d), 127.24 (d), 127.68 (d) 127.75 (d), 128.25 (d), 128.40
(d), 128.53 (d), 128.95 (d), 129.09 (d), 129.75 (d), 131.86 (d), 133.26 (s),
137.63 (s), 139.04 (s), 142.19 (s), 165.51 ppm (s, C-3), one signal (s) was
Chem. Eur. J. 2006, 12, 7467 – 7481
ꢀ 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
7479